AstraZeneca Vaccine Carries Slightly Higher Risk of Bleeding Disorders, Study Shows

June 9, 2021

(New York Times) – People receiving the Covid vaccine made by Oxford-AstraZeneca had a slightly increased risk of a bleeding disorder, and possibly other rare blood problems, researchers reported on Wednesday. The findings, from a study of 2.53 million adults in Scotland who received their first doses of either the AstraZeneca vaccine or the one made by Pfizer-BioNTech, were published in the journal Nature Medicine. About 1.7 million of the shots were the AstraZeneca vaccine. The study found no increased risk of the blood disorders with the Pfizer-BioNTech vaccine. (Read Full Article)